Deshpande, Deepti R. http://orcid.org/0000-0003-3815-2416
Demirdag, Yesim Y.
Marsh, Rebecca A.
Sullivan, Kathleen E.
Orange, Jordan S.
,
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (U24AI086037)
Article History
Received: 16 June 2020
Accepted: 24 August 2020
First Online: 19 September 2020
Compliance with Ethical Standards
:
: Deepti R. Deshpande reports that she is employed by Regeneron Pharmaceuticals and her spouse is employed by Bristol Myers Squibb.Kathleen E. Sullivan reports grants from the Immune Deficiency Foundation during the conduct of the study; reports personal fees from Elsevier, UpToDate, and Immune Deficiency Foundation outside the submitted work.Jordan S. Orange reports personal fees from Enzyvant, CSL Behring, Grifols, ADMA Biologics, Gigagen, Takeda, and Sigilon outside the submitted work.Yesim Y Demirdag and Rebecca A. Marsh report no conflict of interest.
: Manuscript has been approved by the USIDNET Steering Committee.